Procalcitonin is a prognosis biomarker in very preterm neonates with late onset sepsis: a pilot study
- PMID: 34850276
- DOI: 10.1007/s00431-021-04326-2
Procalcitonin is a prognosis biomarker in very preterm neonates with late onset sepsis: a pilot study
Abstract
Neonatal sepsis contributes substantially to neonatal morbidity and mortality. Procalcitonin (PCT) is a recognized biomarker for the diagnosis of late-onset neonatal sepsis (LONS); however, little is known about the prognosis value of PCT in LONS. This study aims at assessing PCT value as a prognosis biomarker in preterm infants with LONS. Retrospective single center observational cohort study. All premature infants (less than 32 weeks of gestational age) with LONS admitted in a tertiary neonatal intensive care unit. Among the 59 preterm infants included in the analysis, 48 survived (81.4%, 48/59). Deceased patients had a significantly lower postmenstrual age (30 [29-32] vs. 28 [27-30], p = 0.025) and weight (1072 [850-1320] vs. 820 [730-1065], p = 0.016) at the time of LONS diagnosis. Although PCT values were not different between both groups at the time of LONS diagnosis, it was more elevated during the first 24 h in deceased patients (12 [1.1-20.3] vs. 1.57 [0.6-4.1], p = 0.041). Accuracy of PCT for predicting 60-day mortality in preterm neonates with LONS ranged from 0.70 to 0.82 of area under the curve on receiver operating characteristic curves. Optimal PCT cut-off values at LONS diagnosis was 8.92 µg/L, 15.75 µg/L for PCT values during the first 24 h, and 6.74 µg/L between 24 and 48 h after diagnosis. The estimated survival probability at day 60 was above 95% for patient with a PCT value at sepsis diagnosis under 8.92 µg/L and less than 45% if higher (p < 0.0001).
Conclusion: A PCT value > 8.92 µg/L obtained at LONS diagnosis suspicion seems to be a good prognosis biomarker.
What is known: •Procalcitonin (PCT) is a recognized biomarker of 28-day mortality in critically ill adults with septic shock and trauma. •Failure to have decreased in PCT in the first days of critical care is associated with increased mortality.
What is new: •Hereby, we show that PCT has a prognosis value in premature infants with late-onset neonatal sepsis. •Procalcitonin value > 8.92 µg/L at LONS diagnosis is associated with an increase at 60-day mortality.
Keywords: LONS; Mortality; Neonatal sepsis; PCT; Prognosis.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Comment in
-
Is procalcitonin a valuable tool in predicting 60-day mortality in premature infants with late onset neonatal sepsis?Eur J Pediatr. 2022 Sep;181(9):3555. doi: 10.1007/s00431-022-04521-9. Epub 2022 Jun 7. Eur J Pediatr. 2022. PMID: 35670868 No abstract available.
References
-
- Stoll BJ, Hansen NI, Bell EF et al (2010) Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 126(3):443–456. https://doi.org/10.1542/peds.2009-2959 - DOI - PubMed
-
- Perlman, Sharon E et al (2007) Risk factors for late-onset health care-associated bloodstream infections in patients in neonatal intensive care units. Am j infection control 35(3):177–82. https://doi.org/10.1016/j.ajic.2006.01.002
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical